: Psoriasis is a immune-mediated, chronic, inflammatory skin dis-ease. In HIV positive (HIV+) patients we usually observe more serious clinical features and recalcitrant course. Furthermore, therapeutic man-agement of HIV+ patient is complex and requires collaboration with the infectious disease specialist. We report the case of a patient affected by severe psoriasis who contracted HIV infection during biological therapy and, subsequently, succesfully treated with ixekizumab.
HIV positive patient treated with ixekizumab / Bernardini, N; Skroza, N; Tolino, E; Marchesiello, A; Mambrin, A; Balduzzi, V; Michelini, S; Maddalena, P; Volpe, S; Proietti, I; Potenza, C. - In: LA CLINICA TERAPEUTICA. - ISSN 1972-6007. - 173:3(2022), pp. 195-197. [10.7417/CT.2022.2416]
HIV positive patient treated with ixekizumab
Bernardini N
;Skroza N;Tolino E;Marchesiello A;Mambrin A;Balduzzi V;Michelini S;Maddalena P;Volpe S;Proietti I;Potenza C
2022
Abstract
: Psoriasis is a immune-mediated, chronic, inflammatory skin dis-ease. In HIV positive (HIV+) patients we usually observe more serious clinical features and recalcitrant course. Furthermore, therapeutic man-agement of HIV+ patient is complex and requires collaboration with the infectious disease specialist. We report the case of a patient affected by severe psoriasis who contracted HIV infection during biological therapy and, subsequently, succesfully treated with ixekizumab.| File | Dimensione | Formato | |
|---|---|---|---|
|
Bernardini_HIV_2022.pdf
solo gestori archivio
Tipologia:
Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza:
Tutti i diritti riservati (All rights reserved)
Dimensione
116.39 kB
Formato
Adobe PDF
|
116.39 kB | Adobe PDF | Contatta l'autore |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
